Anticoagulation in non-valvular atrial fibrillation (NVAF): BSW Guidance for Prescribers
Anticoagulation anticoagulant nvaf atrial fibrillation af doac noac edoxaban apixaban rivaroxaban dabigatran eliquis lixiana xarelto Pradaxa switching IIF
About The BSW APC
APC Recent Decisions March 2022
otigo otitis media phenazone hayfever allergic rhinitis allergy rifaximin denosumab prolia osteoporosis alprostadil aviptadil phentolamine invicorp vitaros edoxaban liothyronine T3 thyroid
BSW Guidance on Prescribing for Hay Fever and Allergic Rhinitis
hayfever antihistamines intranasal corticosteriods eyedrops pollen mometasone beclometasone budesonide fluticasone azelastine ipratropium ceterizine loratadine chlorphenamine acrivastine fexofenadine sodium cromoglicate olopatadine
APC Recent Decisions February 2022
Tolterodine trospium inclisiran HRT bimekizumab epistatus midazolam co-enzyme Q10 ubidecarenone ubiquinone rivaroxaban Xarelto paxlovid ciprofloxacin eardrops diprobase limbo sealtight waterproof
BSW Denosumab Shared Care Guideline for Osteoporosis
prolia postmenopausal postmenopausal osteoporosis
BSW Epistatus® (Oromucosal Buccal Midazolam) for children over 10 years of age
Midazolam buccolam buccal epilepsy status epilepticus seizure fits fitting
BSW Epistatus® (Oromucosal Buccal Midazolam) for children under 10 years of age (unlicensed use)
epilepsy fitting fits epileptic fit seizure buccolam status epilepticus